Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Glaukos Corp
(NY:
GKOS
)
109.79
-0.62 (-0.56%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Glaukos Corp
< Previous
1
2
3
4
5
Next >
25 Stocks Moving in Wednesday's Pre-Market Session
November 03, 2021
Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...
Via
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
Why Glaukos Shares Dipped Today
July 20, 2021
Glaukos (NYSE:GKOS) shares are trading lower after Wells Far...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
Glaukos plunges after CMS suggests slashing iStent reimbursement
July 14, 2021
William Blair downgraded Glaukos following the
Via
Talk Markets
Ivantis To Pay $60M In Patent Litigation Settlement With Glaukos
September 15, 2021
Glaukos Corp (NYSE:GKOS) has
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Glaukos Files Pre-Market Application For Intraocular Pressure Device
September 03, 2021
Glaukos Corp (NYSE: GKOS) has submitted a supplemental premarket approval (PMA) application to the FDA for its iStent infinite Trabecular Micro-Bypass System....
Via
Benzinga
Exposures
Product Safety
Return on Capital Employed Overview: Glaukos
September 01, 2021
Pulled from Benzinga Pro data Glaukos (NYSE:GKOS) reported Q2 sales of $78.09 million. Earnings fell to a loss of $14.22 million, resulting in a 20.47% decrease from last quarter...
Via
Benzinga
Glaukos Guided Below Consensus After Q2 Earnings; Analysts Cut Price Target
August 06, 2021
Glaukos Corporation (NYSE:GKOS)
Via
Benzinga
Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript
August 06, 2021
GKOS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Glaukos Stock Sank Today
July 20, 2021
An analyst downgraded the healthcare stock.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021
July 26, 2021
Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE:
Via
Benzinga
62 Biggest Movers From Yesterday
July 21, 2021
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...
Via
Benzinga
Exposures
Product Safety
Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts
July 20, 2021
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ:
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge
July 14, 2021
Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to 4,380.58. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 14, 2021
Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX
Via
Benzinga
55 Biggest Movers From Yesterday
July 15, 2021
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by...
Via
Benzinga
Mid-Day Market Update: Aspen Group Drops Following Q4 Results; Datasea Shares Surge
July 14, 2021
Midway through trading Wednesday, the Dow traded up 0.05% to 34,907.35 while the NASDAQ rose 0.48% to 14,747.61. The S&P also rose, gaining 0.24% to 4,379.85. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
34 Stocks Moving In Wednesday's Mid-Day Session
July 14, 2021
Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution...
Via
Benzinga
Why Glaukos Stock Is Tanking Today
July 14, 2021
Proposed rates from CMS for fiscal 2022 weren't what investors expected.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations
July 14, 2021
Following the market opening Wednesday, the Dow traded up 0.26% to 34,979.05 while the NASDAQ rose 0.40% to 14,736.66. The S&P also rose, gaining 0.30% to 4,382.38. The U.S....
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
July 14, 2021
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 14, 2021
Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop
July 14, 2021
Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure...
Via
Benzinga
Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level
July 01, 2021
Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist?
Via
Investor's Business Daily
Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript
May 05, 2021
GKOS earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.